Cabazitaxel

Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.

单词	Cabazitaxel
释义	Cabazitaxel 英语百科 Cabazitaxel Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
随便看	Slide show SlideShow slide show audiometer slide show audiometry slide shows Slideshows Slide Show view slide ,slip slideslipping slide slope stabilization slide solid phase antibody adsorption immunoflu orescence Slide Sorter slides out slide speed slide spring slide stainer slide staining machine slide step Slide stop slide stroke slide surface slide switch slide switch for tap changing slide swwitch slide sync recorder